UK's Cma - Anticipated Acquisition by Theramex of European Rights to Viatris' Femoston, Duphaston Products Will Not Be Referred to an in-Depth Probe
英國CMA:Theramex對Viatris Femoston、Duphaston產品在歐洲權利的預期收購將不會被提交深度調查。
UK's Cma - Anticipated Acquisition by Theramex of European Rights to Viatris' Femoston, Duphaston Products Will Not Be Referred to an in-Depth Probe
英國CMA:Theramex對Viatris Femoston、Duphaston產品在歐洲權利的預期收購將不會被提交深度調查。
譯文內容由第三人軟體翻譯。